HONG KONG, April 12, 2021 – Sisram Medical Ltd (“Sisram” or “the Company”) (Hong Kong: 1696), an operational holding company specializing in medical aesthetics technology for wellness, today announced that its wholly owned subsidiary Alma has unveiled the new Alma PrimeXTM platform, during a worldwide LIVE launch event, which was broadcasted from it headquarter studio. 

Alma PrimeXTM, the stand-out performer in its category, achieves unparalleled results in circumference reduction and skin tightening in the abdomen, waist, thighs and buttocks areas. Alma PrimeXTM was designed and built with doctors and patients in mind. Adhering to Alma’s Business to Everyone strategy, focused on customers and consumers, the Alma PrimeX’ s research and development process was initiated on the user side, putting his needs at heart. A multinational research and development team, operated research sites spread across 3 geographies – South Korea, Spain and Israel, to tailor the technologies and treatments to various ethnicities, demographics and cultures – with the guidance of leading key opinion leaders and their clientele. 

At the core of PrimeXTM is Alma’s proprietary combination of legacy Ultrasound and Radiofrequency technologies. The synergistic combination is powered by: 

 Alma’s patented Guided Ultrasound waves, selectively affecting adipose tissue and resulting in a reduction in fat thickness evident in remarkable clinical results.

 Alma’s patented UniPolar Radio Frequency, effectively heating the dermal and subcutaneous layers, targeting collagen and elastin fibers, and promoting new collagen formation. 

The combined technologies are further enriched by four revolutionary features, delivering the X factor, with every treatment:  ConeX - A unique cone-shaped cavity which amplifies acoustic waves, decreases reflection of ultrasound waves, and has no central hot spot.  Impulse - Ultrasound energy delivered in pulses, rather than continuously, through a mechanical effect that creates minor shockwaves making the treatment more effective.  MaXimize - A vacuum feature to maintain continuous coupling between the applicator and the skin, ensures maximal and uniform ultrasound delivery to the treatment area, thus maximizing results.  ReACCT - Tissue characteristics calibration and energy output control, enables systematic optimization. Automatic ultrasound frequency and power adjustmentsthroughout the session to suit the patient's skin condition. 

“We are proud to lead a new era in medical aesthetics devices – addressing technology as means for an improved user & patient experience, rather than a goal. Alma PrimeXTM offers a whole new experience for practitioners as well as patients, putting their needs and wants at the center of our operation“ said Lior Dayan, CEO of Alma and Sisram Medical. 

###

About Sisram Medical Ltd 

Sisram Medical Ltd (1696.HK) is one of the top 5 global leaders in the energy-based medical aesthetics industry. The company is majority held by Fosun Pharma, a leading healthcare group in China. Sisram Medical successfully went public on September 19, 2017, as the first Israeli company listed on the Hong Kong Exchange Main Board. Sisram Medical’s core subsidiary, Alma, is a global leading provider of energy-based surgical and medical aesthetics solutions and is active across over 90 countries and jurisdictions worldwide. Flagship systems of Sisram Medical include (i) the “Soprano” family, primarily used for laser hair removal; (ii) the “Harmony” family, a versatile multi-application platform that can be used to treat more than 65 different FDA-cleared indications; (iii) the “Accent” family, primarily used for body contouring and skin tightening; (iv) “FemiLift”, a minimally invasive treatment system for various feminine conditions; and (v) “BeautiFill” by LipoFlow platform, the first and only energy-based device cleared by the FDA for autologous fat grafting. In addition, Sisram Medical also entered the injectables market, with products available in Israel, Hong Kong and India. 

Sisram Medical –Enhancing Quality of Life. 

http://www.sisram-medical.com 

For media inquiries, please contact: 

ICR Inc. Edmond Lococo 

Tel: +86 138-1079-1408 

E-mail: Edmond.lococo@icrinc.com